PAX3 and metastatic neoplasm: The heterogeneity of Pax3:Foxo1a expression in primary and metastatic tumors, and enrichment in the latter, suggested that Pax3:Foxo1a might be selectively expressed in a subset of aRMS cells; alternatively, Pax3:Foxo1a expression might be temporally regulated.